Media Summary: Amy Abernethy, MD, PhD, Deputy Commissioner, FDA, discusses the implications of
Can Ai Improve Endpoint Data In Clinical Trials Trials And Treatments Uncovered - Detailed Analysis & Overview
Amy Abernethy, MD, PhD, Deputy Commissioner, FDA, discusses the implications of